Svetlana Goločorbin Kon

Associate Professor

Faculty of Medicine, Department of Pharmacy

svetlana.golocorbin-kon@mf.uns.ac.rs

Phone: 021422760

ORCID ID :

Academic career	Year	Institution	Field
PhD	2009	Faculty of Medicine Novi Sad	Pharmaceutical Technology - Technology
Specialization	2006	Faculty of Pharmacy Beograd	Pharmaceutical Technology
MSc	2004	Faculty of Medicine Novi Sad	Pharmaceutical Technology - Technology
Graduated	1980	Faculty of Pharmacy Beograd	Pharmacy

Academic career

Year

Institution

Field

PhD

2009

Faculty of Medicine Novi Sad

Pharmaceutical Technology - Technology

Specialization

2006

Faculty of Pharmacy Beograd

Pharmaceutical Technology

MSc

2004

Faculty of Medicine Novi Sad

Pharmaceutical Technology - Technology

Graduated

1980

Faculty of Pharmacy Beograd

Pharmacy

M	Description
23	Kecman Sanja, Skrbic Ranko, Badnjevic-Cengic Alma, Mooranian Armin, Al-Salami Hani, Mikov Momir, Golocorbin-Kon Svetlana. Potentials of human bile acids and their salts in pharmaceutical nano delivery and formulations adjuvants. TECHNOLOGY AND HEALTH CARE, (2020), vol. 28 br. 3, str. 325-335
21	Wagle Susbin Raj, Walker Daniel, Kovacevic Bozica, Gedawy Ahmed, Mikov Momir M, Golocorbin-Kon Svetlana, Mooranian Armin. Micro-Nano formulation of bile-gut delivery: rheological, stability and cell survival, basal and maximum respiration studies . Sci Rep 10, 7715 (2020). https://doi.org/10.1038/s41598-020-64355-z
23	Maksimovic Vladimir, Pavlovic-Popovic Zora, Vukmirovic Sasa N, Cvejic Jelena M, Mooranian Armin Al-Salami Hani, Mikov Momir M, Golocorbin-Kon Svetlana. Molecular mechanism of action and pharmacokinetic properties of methotrexate. MOLECULAR BIOLOGY REPORTS, (2020)
22	Mooranian Armin, Zamani Nassim, Ionescu Corina M, Takechi Ryu, Luna Giuseppe, Mikov Momir M, Golocorbin-Kon Svetlana, Kovacevic Bozica, Al-Salami Hani. Oral gavage of nano-encapsulated conjugated acrylic acid-bile acid formulation in type 1 diabetes altered pharmacological profile of bile acids, and improved glycaemia and suppressed inflammation. PHARMACOLOGICAL REPORTS, (2020), vol. 72 br. 2, str. 368-378.
21	Mooranian Armin, Wagle Susbin Raj, Kovacevic Bozica, Takechi Ryu, Mamo John, Lam Virginie, Watts Gerald F, Mikov Momir M, Golocorbin-Kon Svetlana, Stojanovic Goran M, Al-Sallami Hesham S, Al-Salami Hani. Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study. SCIENTIFIC REPORTS, (2020), vol. 10 br. 1.
23	Svonja-Parezanovic Gordana, Lalic-Popovic Mladena, Golocorbin-Kon Svetlana, Todorovic Nemanja B, Pavlovic Nebojsa, Mikov Momir M. In Vitro Comparative Quality Evaluation of Non-Expired and 10 Years-Expired Lamotrigine Immediate-Release Tablet Formulations - Pilot Study. DISSOLUTION TECHNOLOGIES, (2020), vol. 27 br. 1.
21	Paut-Kusturica Milica M, Golocorbin-Kon Svetlana, Ostojic Tijana, Kresoja Milena S, Milovic Marko J, Horvat Olga J, Dugandzija Tihomir, Davidovac Nada, Vasic Anica, Tomas Ana D. Consumer willingness to pay for a pharmaceutical disposal program in Serbia: A double hurdle modeling approach. WASTE MANAGEMENT, (2020), vol. 104 br. , str. 246-253.
23	Mikov Momir M, Pavlovic Nebojsa, Stanimirov Bojan G, Djanic Maja, Golocorbin-Kon Svetlana , Stankov Karmen M, Al-Salami Hani. DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal Impairment. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, (2020), vol. 45 br. 1, str. 1-14. DOI: 10.1007/s13318-019-00570-y
21	Mooranian Armin, Zamani Nassim, Mikov Momir M, Golocorbin-Kon Svetlana, Stojanovic Goran Arfuso Frank ,Kovacevic Bozica ,Al-Salami Hani. A second-generation micro/nano capsules of an endogenous primary un-metabolised bile acid, stabilized by Eudragit-alginate complex with antioxidant compounds. SAUDI PHARMACEUTICAL JOURNAL, (2020), vol. 28 br. 2, str. 165-171.
22	Bjelica Artur L, Aleksic Sanja, Golocorbin-Kon Svetlana, Sazdanic Darija, Torovic Ljilja D, Cvejic Jelena M. Internet Marketing of Cardioprotective Dietary Supplements. J Altern Complement Med. 2020;26(3):204-211. doi:10.1089/acm.2019.0128
22	Pavlovic Nebojsa , Djanic Maja, Stanimirov Bojan G, Golocorbin-Kon Svetlana, Stankov Karmen M, Lalic-Popovic Mladena, Mikov Momir M. In silico Discovery of Resveratrol Analogues as Potential Agents in Treatment of Metabolic Disorders. CURRENT PHARMACEUTICAL DESIGN, (2019), vol. 25 br. 35, str. 3776-3783.
21а	Lazarević S, Đanic M, Goločorbin-Kon S, Al-Salami H, Mikov M. Semisynthetic bile acids: a new therapeutic option for metabolic syndrome. Pharmacological Research. June 2019. DOI: 10.1016/j.phrs.2019.104333
21	Mooranian Armin, Zamani Nassim, Luna Giuseppe, Al-Sallami Hesham S, Mikov Momir M, Golocorbin-Kon Svetlana, Stojanovic Goran M, Arfuso Frank, Kovacevic Bozica, Al-Salami Hani. Bile acid-polymer-probucol microparticles: protective effect on pancreatic ?-cells and decrease in type 1 diabetes development in a murine model. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, (2019), vol. 24 br. 10, str. 1272-1277.
22	Švonja Parezanović G, Lalic-Popovic M, Golocorbin-Kon S, Vasovic V, Milijasevic B, Al-Salami H, Mikov M. Environmental Transformation of Pharmaceutical Formulations: A Scientific Review, Archives of Environmental Contamination and Toxicology 77(8), June 2019. DOI: 10.1007/s00244-019-00630-z
21	Mooranian A, Zamani N, Takechi R, Luna G, Mikov M, Golocorbin - Kon S, Elnashar M, Arfuso F, Al-Salami H. An in vivo pharmacological study: Variation in tissue-accumulation for the drug probucol as the result of targeted microtechnology and matrix-acrylic acid optimization and stabilization techniques. PLoS ONE 14(4):e0214984. April 2019. DOI: 10.1371/journal.pone.0214984
21	Mooranian A, Zamani N, Mikov M, Golocorbin-Kon S, Stojanovic G, Arfuso F, Al-Salami H. Eudragit ® -based microcapsules of probucol with a gut-bacterial processed secondary bile acid . Therapeutic delivery. November 2018.
21	Đanic M, Stanimirov B, Pavlovic N, Golocorbin-Kon S, Al-Salami H, Stankov K, Mikov M. Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome. Frontiers in Pharmacology 9. December 2018. DOI: 10.3389/fphar.2018.01382
21	Pavlovic N, Golocorbin-Kon S, Đanic M, Stanimirov B, Al-Salami H, Stankov K, Mikov M. Bile Acids and Their Derivatives as Potential Modifiers of Drug Release and Pharmacokinetic Profiles. Frontiers in Pharmacology. November 2018. DOI: 10.3389/fphar.2018.01283
23	Golocorbin-Kon S, Calasan J, Milijasevic B, Vukmirovic S, Lalic-Popovic M, Mikov M, Al-Salami H. High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect. Eur J Drug Metab Pharmacokinet (2017). DOI:10.1007/s13318-017-0415-0.
23	Golocorbin-Kon S, Mikov M, Cvejic Hogervorst J, Al-Salami H, Maksimovic V. Dried blood spot: Utilising dry blood for pharmacokinetic investigations-an old method with great future for therapeutic drug monitorin. Vojnosanitetski pregled. 2017; DOI: 10.2298/VSP170130046G.

Description

Kecman Sanja, Skrbic Ranko, Badnjevic-Cengic Alma, Mooranian Armin, Al-Salami Hani, Mikov Momir, Golocorbin-Kon Svetlana. Potentials of human bile acids and their salts in pharmaceutical nano delivery and formulations adjuvants. TECHNOLOGY AND HEALTH CARE, (2020), vol. 28 br. 3, str. 325-335

Wagle Susbin Raj, Walker Daniel, Kovacevic Bozica, Gedawy Ahmed, Mikov Momir M, Golocorbin-Kon Svetlana, Mooranian Armin. Micro-Nano formulation of bile-gut delivery: rheological, stability and cell survival, basal and maximum respiration studies . Sci Rep 10, 7715 (2020). https://doi.org/10.1038/s41598-020-64355-z

Maksimovic Vladimir, Pavlovic-Popovic Zora, Vukmirovic Sasa N, Cvejic Jelena M, Mooranian Armin Al-Salami Hani, Mikov Momir M, Golocorbin-Kon Svetlana. Molecular mechanism of action and pharmacokinetic properties of methotrexate. MOLECULAR BIOLOGY REPORTS, (2020)

Mooranian Armin, Zamani Nassim, Ionescu Corina M, Takechi Ryu, Luna Giuseppe, Mikov Momir M, Golocorbin-Kon Svetlana, Kovacevic Bozica, Al-Salami Hani. Oral gavage of nano-encapsulated conjugated acrylic acid-bile acid formulation in type 1 diabetes altered pharmacological profile of bile acids, and improved glycaemia and suppressed inflammation. PHARMACOLOGICAL REPORTS, (2020), vol. 72 br. 2, str. 368-378.

Mooranian Armin, Wagle Susbin Raj, Kovacevic Bozica, Takechi Ryu, Mamo John, Lam Virginie, Watts Gerald F, Mikov Momir M, Golocorbin-Kon Svetlana, Stojanovic Goran M, Al-Sallami Hesham S, Al-Salami Hani. Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study. SCIENTIFIC REPORTS, (2020), vol. 10 br. 1.

Svonja-Parezanovic Gordana, Lalic-Popovic Mladena, Golocorbin-Kon Svetlana, Todorovic Nemanja B, Pavlovic Nebojsa, Mikov Momir M. In Vitro Comparative Quality Evaluation of Non-Expired and 10 Years-Expired Lamotrigine Immediate-Release Tablet Formulations - Pilot Study. DISSOLUTION TECHNOLOGIES, (2020), vol. 27 br. 1.

Paut-Kusturica Milica M, Golocorbin-Kon Svetlana, Ostojic Tijana, Kresoja Milena S, Milovic Marko J, Horvat Olga J, Dugandzija Tihomir, Davidovac Nada, Vasic Anica, Tomas Ana D. Consumer willingness to pay for a pharmaceutical disposal program in Serbia: A double hurdle modeling approach. WASTE MANAGEMENT, (2020), vol. 104 br. , str. 246-253.

Mikov Momir M, Pavlovic Nebojsa, Stanimirov Bojan G, Djanic Maja, Golocorbin-Kon Svetlana , Stankov Karmen M, Al-Salami Hani. DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal Impairment. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, (2020), vol. 45 br. 1, str. 1-14. DOI: 10.1007/s13318-019-00570-y

Mooranian Armin, Zamani Nassim, Mikov Momir M, Golocorbin-Kon Svetlana, Stojanovic Goran Arfuso Frank ,Kovacevic Bozica ,Al-Salami Hani. A second-generation micro/nano capsules of an endogenous primary un-metabolised bile acid, stabilized by Eudragit-alginate complex with antioxidant compounds. SAUDI PHARMACEUTICAL JOURNAL, (2020), vol. 28 br. 2, str. 165-171.

Bjelica Artur L, Aleksic Sanja, Golocorbin-Kon Svetlana, Sazdanic Darija, Torovic Ljilja D, Cvejic Jelena M. Internet Marketing of Cardioprotective Dietary Supplements. J Altern Complement Med. 2020;26(3):204-211. doi:10.1089/acm.2019.0128

Pavlovic Nebojsa , Djanic Maja, Stanimirov Bojan G, Golocorbin-Kon Svetlana, Stankov Karmen M, Lalic-Popovic Mladena, Mikov Momir M. In silico Discovery of Resveratrol Analogues as Potential Agents in Treatment of Metabolic Disorders. CURRENT PHARMACEUTICAL DESIGN, (2019), vol. 25 br. 35, str. 3776-3783.

21а

Lazarević S, Đanic M, Goločorbin-Kon S, Al-Salami H, Mikov M. Semisynthetic bile acids: a new therapeutic option for metabolic syndrome. Pharmacological Research. June 2019. DOI: 10.1016/j.phrs.2019.104333

Mooranian Armin, Zamani Nassim, Luna Giuseppe, Al-Sallami Hesham S, Mikov Momir M, Golocorbin-Kon Svetlana, Stojanovic Goran M, Arfuso Frank, Kovacevic Bozica, Al-Salami Hani. Bile acid-polymer-probucol microparticles: protective effect on pancreatic ?-cells and decrease in type 1 diabetes development in a murine model. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, (2019), vol. 24 br. 10, str. 1272-1277.

Švonja Parezanović G, Lalic-Popovic M, Golocorbin-Kon S, Vasovic V, Milijasevic B, Al-Salami H, Mikov M. Environmental Transformation of Pharmaceutical Formulations: A Scientific Review, Archives of Environmental Contamination and Toxicology 77(8), June 2019. DOI: 10.1007/s00244-019-00630-z

Mooranian A, Zamani N, Takechi R, Luna G, Mikov M, Golocorbin - Kon S, Elnashar M, Arfuso F, Al-Salami H. An in vivo pharmacological study: Variation in tissue-accumulation for the drug probucol as the result of targeted microtechnology and matrix-acrylic acid optimization and stabilization techniques. PLoS ONE 14(4):e0214984. April 2019. DOI: 10.1371/journal.pone.0214984

Mooranian A, Zamani N, Mikov M, Golocorbin-Kon S, Stojanovic G, Arfuso F, Al-Salami H. Eudragit ® -based microcapsules of probucol with a gut-bacterial processed secondary bile acid . Therapeutic delivery. November 2018.

Đanic M, Stanimirov B, Pavlovic N, Golocorbin-Kon S, Al-Salami H, Stankov K, Mikov M. Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome. Frontiers in Pharmacology 9. December 2018. DOI: 10.3389/fphar.2018.01382

Pavlovic N, Golocorbin-Kon S, Đanic M, Stanimirov B, Al-Salami H, Stankov K, Mikov M. Bile Acids and Their Derivatives as Potential Modifiers of Drug Release and Pharmacokinetic Profiles. Frontiers in Pharmacology. November 2018. DOI: 10.3389/fphar.2018.01283

Golocorbin-Kon S, Calasan J, Milijasevic B, Vukmirovic S, Lalic-Popovic M, Mikov M, Al-Salami H. High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect. Eur J Drug Metab Pharmacokinet (2017). DOI:10.1007/s13318-017-0415-0.

Golocorbin-Kon S, Mikov M, Cvejic Hogervorst J, Al-Salami H, Maksimovic V. Dried blood spot: Utilising dry blood for pharmacokinetic investigations-an old method with great future for therapeutic drug monitorin. Vojnosanitetski pregled. 2017; DOI: 10.2298/VSP170130046G.

Course	Studies
Pharmaceutical technology I	Integrated Academic Studies in Pharmacy
Pharmaceutical technology II	Integrated Academic Studies in Pharmacy
Pharmaceutical technology III	Integrated Academic Studies in Pharmacy
Pharmacy practice	Integrated Academic Studies in Pharmacy
Dermocosmetic preparation	Integrated Academic Studies in Pharmacy
Pharmaceutical marketing	Integrated Academic Studies in Pharmacy
Clinical Pharmacy	Specialization for pharmacy students

Course

Studies

Pharmaceutical technology I